NIH-funded research R21 grant

Preparing for clinical trials in a rare visual dementia condition

Official title: Clinical Trial Readiness for Posterior Cortical Atrophy Syndrome

Funded at University of Colorado Denver · NIH-10948819 · Data updated 2026-11-12

This study is looking for 25 people with posterior cortical atrophy (PCA), a rare condition that affects vision and is often related to Alzheimer's, to help gather important information over a year so we can better understand PCA and prepare for future treatments that fit the specific challenges of this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$429,000
NIH project number1R21TR004695-01A1
Project IDNIH-10948819 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with posterior cortical atrophy, particularly those aged between 50 and 64 years.

Less likely to help

Patients with other forms of dementia that do not present with visual dysfunction may not benefit from this research.

What this research studies

This research focuses on the rare syndrome of posterior cortical atrophy (PCA), which is characterized by progressive visual dysfunction and is often linked to Alzheimer's disease. The project aims to gather important longitudinal data through clinical outcome assessments and plasma biomarkers to facilitate the readiness for clinical trials using existing therapeutic candidates. By enrolling 25 individuals diagnosed with PCA, the research will assess specific outcomes related to this condition over a year, addressing the unique challenges faced in traditional Alzheimer's trials that typically focus on memory impairment. This approach seeks to develop tailored assessment tools that reflect the distinct symptoms of PCA.

Why it matters

Potential benefit: If successful, this research could lead to improved clinical trial designs and better therapeutic options for patients with posterior cortical atrophy.

How similar studies have gone: While research on posterior cortical atrophy is limited, the approach of developing specific outcome measures for unique dementia presentations has shown promise in other studies.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Pelak, Victoria Susan — University of Colorado Denver
  • Study coordinator: Pelak, Victoria Susan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.